This binding triggers several important physiological responses: enhanced insulin secretion from pancreatic beta cells in response to elevated blood glucose, suppression of glucagon release (which normally raises blood sugar), delayed gastric emptying (slowing food passage from stomach to intestine), and increased satiety through effects on appetite centres in the brain
Numerous studies, demonstrate a marked enhancement in glycemic parameters, including FPG, 2h-OGTT, HbA1c, and HOMA-IR, when administered at a daily dosage of 500 mg over 12 weeks (Table 4, Table 5)
In addition, more weight loss was observed with GLP-1 analogs compared to placebo or other antidiabetic drugs [31]
They are not for human consumption, not for medical or veterinary use, and not approved by the FDA or any regulatory authority